NCT00967837

Brief Summary

One of the significant complications associated with some patients with diabetes is the inability for wounds to heal regardless of enrolling and participating in a traditional wound healing program. There have been a number of anecdotal evidence presented by patients receiving pulsatile intravenous insulin therapy for other complications with non healing wounds lasting from several months to several years whose wounds healed while receiving therapy. This study was designed to specifically monitor the progress of diabetic patients who have failed traditional wound care therapy and monitor the progress of their wounds while receiving pulsatile intravenous insulin therapy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
152

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jan 2006

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

August 6, 2009

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 28, 2009

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

August 10, 2016

Status Verified

August 1, 2016

Enrollment Period

6 years

First QC Date

August 6, 2009

Last Update Submit

August 8, 2016

Conditions

Keywords

Diabetes with complicationsWound healing

Outcome Measures

Primary Outcomes (1)

  • To measure progress of wound healing in subjects that have failed conventional wound care healing treatments for 60 days

    Monitoring of wound is done at baseline and weekly follow up visits including visual examination, pictures of wound and measurements

Study Arms (1)

Diabetes with non healing wounds

EXPERIMENTAL

To determine and monitor progress of diabetic patients with non healing wounds that have failed conventional 60 day treatment respond to pulsatile intravenous insulin therapy in improving and completing healing in non healing wounds

Procedure: Pulsatile Intravenous Insulin Therapy

Interventions

Diabetic pts that meet trial criteria referred by an endocrinologist are given Pulsatile intravenous insulin therapy on a weekly basis. Weekly orders for insulin dosage is based upon pt response to therapy monitored by RQ and insulin resistance.

Also known as: Humulin, Humulin R, Novolog
Diabetes with non healing wounds

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with type 1 or type 2 diabetes
  • taking oral and/or insulin for diabetes control
  • endocrinologist must assess and approve pt for participation in study
  • ability to swallow without difficulty
  • ability to meet weekly time and testing requirements for this study

You may not qualify if:

  • inability to do testing required for study including regular scheduled visits for independent review of non healing wound including assessment, pictures and measurements
  • lack of intravenous access
  • alcohol abuse, drug addiction or the use of illegal drugs
  • positive HIV
  • active liver disease
  • in active treatment for cancer including radiation or chemotherapy
  • inability to breathe into machine for respiratory quotients to monitor progress

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida Atlantic University

Boca Raton, Florida, 33487, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Interventions

Insulin, Regular, HumanInsulinInsulin Aspart

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

ProinsulinInsulinsPancreatic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and ProteinsInsulin, Short-Acting

Study Officials

  • Betty Tuller, PhD

    Florida Atlantic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2009

First Posted

August 28, 2009

Study Start

January 1, 2006

Primary Completion

January 1, 2012

Study Completion

September 1, 2012

Last Updated

August 10, 2016

Record last verified: 2016-08

Locations